Results 211 to 220 of about 2,457,946 (249)
Some of the next articles are maybe not open access.
The Challenge of Invasive Fungal Infection
Chemotherapy, 1999Systemic fungal infections cause almost 25% of the infection-related deaths in leukaemic patients. Particularly those with prolonged neutropenia are at risk but mycoses also feature in critically ill intensive care patients and in individuals who are treated for solid tumours and AIDS, or who received an organ transplant.
B E, de Pauw, F, Meunier
openaire +2 more sources
Immunodiagnosis of invasive fungal infections
Medical Mycology, 1994(1994). Immunodiagnosis of invasive fungal infections. Journal of Medical and Veterinary Mycology: Vol. 32, No. sup1, pp. 239-252.
L, De Repentigny +5 more
openaire +2 more sources
Invasive Fungal Infections in the ICU
Journal of Intensive Care Medicine, 2009Invasive fungal infections are major causes of morbidity and mortality in critically ill patients. Foremost among these is invasive candidiasis. In recent years, invasive aspergillosis (IA) and zygomycosis have emerged as major problems in susceptible, critically ill patients.
Shmuel, Shoham, Shilpa, Marwaha
openaire +2 more sources
Overview of Invasive Fungal Infections
2012The incidence of invasive fungal infections (IFIs) has seen a marked increase in the last two decades. This is especially evident among transplant recipients, patients suffering from AIDS, in addition to those in receipt of immunosuppressive therapy.
Nina L, Tuite, Katrina, Lacey
openaire +2 more sources
Clinical Experience in Invasive Fungal Infections
Clinical Drug Investigation, 2013Lung infections caused by invasive filamentous fungi are very rare conditions in AIDS, but must be considered in patients with profound immune suppression especially in the presence of additional risk factors, such as hematologic malignancies, corticosteroid therapy, neutropenia, and chemotherapy. The authors report a case of dual lung infection caused
Pacheco, P +4 more
openaire +3 more sources
Drugs, 2009
Invasive fungal infections (IFIs) are being increasingly recognized as a major threat in critically ill adult and paediatric patients. They can range widely in severity and can be life threatening in some patients. Candida and Aspergillus species are the most common causes of IFIs, but other yeasts and filamentous fungi are emerging pathogens.
openaire +3 more sources
Invasive fungal infections (IFIs) are being increasingly recognized as a major threat in critically ill adult and paediatric patients. They can range widely in severity and can be life threatening in some patients. Candida and Aspergillus species are the most common causes of IFIs, but other yeasts and filamentous fungi are emerging pathogens.
openaire +3 more sources
2016
Upon completion of the chapter, the reader will be able to: 1. Differentiate epidemiologic differences and host risk factors for acquisition of primary and opportunistic invasive fungal diseases. 2. Recommend appropriate empiric or targeted antifungal therapy for the treatment of invasive fungal disease. 3.
Lewis RE, Rogers PD
openaire +3 more sources
Upon completion of the chapter, the reader will be able to: 1. Differentiate epidemiologic differences and host risk factors for acquisition of primary and opportunistic invasive fungal diseases. 2. Recommend appropriate empiric or targeted antifungal therapy for the treatment of invasive fungal disease. 3.
Lewis RE, Rogers PD
openaire +3 more sources
Antifungal therapy in invasive fungal infections
Current Opinion in Pharmacology, 2010Early treatment of invasive fungal infections (IFIs) is essential for optimal clinical outcomes. Standard antifungal drugs (polyenes, azoles and echinocandins) are not predictably effective against emerging yeasts and filamentous fungi and may cause undesirable side effects. Species identification can guide antifungal selection for invasive candidiasis,
Chen, Sharon C-A. +2 more
openaire +5 more sources
Archives of Internal Medicine, 1983
• Serologic tests are useful in providing a presumptive diagnosis of invasive fungal infection, allowing early institution of specific therapy. The judicious use of these serologic tests for circulating antibodies or antigens also may aid in analyzing response to treatment and in assessing prognosis.
openaire +1 more source
• Serologic tests are useful in providing a presumptive diagnosis of invasive fungal infection, allowing early institution of specific therapy. The judicious use of these serologic tests for circulating antibodies or antigens also may aid in analyzing response to treatment and in assessing prognosis.
openaire +1 more source
Caspofungin in the treatment of invasive fungal infections
Intensive and Critical Care Nursing, 2006Caspofungin is a member of a new class of antifungals called Echinocandins and is the first to have marketing authorisation in the United Kingdom. This article reviews the clinical efficacy, side effect profile, dosing and administration schedule of caspofungin.
Simon, Keady, Meera, Thacker
openaire +2 more sources